Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine

被引:12
作者
Patel, Dasharath M. [1 ]
Patel, Mehul J. [1 ]
Patel, Ankit N. [1 ]
Patel, Chhagan N. [1 ]
机构
[1] Shri Sarvajanik Pharm Coll, Dept Pharmaceut & Pharm Technol, Near Arvind Baug, Mehsana 384001, Gujarat, India
关键词
Buoyancy lag time; full factorial design; Gelucire; 43/01; melt granulation;
D O I
10.4103/2230-973X.93006
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Present investigation describes an influence of ratio of Gelucire 43/01(hydrophobic) to hydroxypropyl methylcellulose K4M (HPMC K4M) (hydrophilic) and different fillers on release of famotidine from gastro-retentive tablets using 32 full factorial design. Ratio of Gelucire 43/01 to HPMC K4M (X-1) and the type of filler (X-2) were selected as independent variables while buoyancy lag time (BLT), drug release at 1h (Q(1)), 6h (Q(6)), and the 12h (Q(12)) were selected as dependent variables. Materials and Methods: Gastro-retentive tablets of famotidine were prepared by a solvent free melt granulation technique using Gelucire 43/01 as a hydrophobic meltable binder. HPMC K4M and sodium bicarbonate were used as matrixing agent and gas-generating agent, respectively. Prepared tablets were evaluated for in vitro dissolution, in vitro buoyancy, friability, hardness, drug content and weight variation. Dissolution data were fitted to various models to ascertain kinetics of drug release. The data were analyzed using regression analysis and analysis of variance. Results: All formulations (F-1 -F-9) showed floating within 3min and had total floating time of more than 12h. It was observed that a type of filler and the ratio of Gelucire 43/01 to HPMC K4M had significant influence on buoyancy lag time (P = 0.037) and Q(6) (P = 0.011), respectively without significant influence on Q(1) and Q(12). Conclusion: Formulation F-5 was selected as an optimum formulation as it showed more similarity in dissolution profile with theoretical profile (Similarity factor, f(2) = 83.01). The dissolution of batch F-5 can be described by zero order kinetics (r(2) = 0.9914) with anomalous (non-Fickian) diffusion as a release mechanism (n = 0.559). The difference observed in in vitro release profile after temperature sensitivity study at 40 degrees C for 1 month was insignificant.
引用
收藏
页码:247 / 254
页数:8
相关论文
共 28 条
[1]   Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18
[2]  
Barik B.B., 2009, ASIAN J PHARM CLIN R, V2, P54
[3]  
CHIEN YW, 1982, NOVEL DRUG DELIVERY, P465
[4]   DRUG RELEASE MODULATION BY PHYSICAL RESTRICTIONS OF MATRIX SWELLING [J].
COLOMBO, P ;
CONTE, U ;
GAZZANIGA, A ;
MAGGI, L ;
SANGALLI, ME ;
PEPPAS, NA ;
LAMANNA, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 63 (01) :43-48
[5]   MULTILAYERED HYDROPHILIC MATRICES AS CONSTANT RELEASE DEVICES (GEOMATRIX(TM) SYSTEMS) [J].
CONTE, U ;
MAGGI, L ;
COLOMBO, P ;
LAMANNA, A .
JOURNAL OF CONTROLLED RELEASE, 1993, 26 (01) :39-47
[6]   Modulation of the dissolution profiles from Geomatrix(R) multi-layer matrix tablets containing drugs of different solubility [J].
Conte, U ;
Maggi, L .
BIOMATERIALS, 1996, 17 (09) :889-896
[7]   A flexible technology for the linear, pulsatile and delayed release of drugs, allowing for easy accommodation of difficult in vitro targets [J].
Conte, U ;
Maggi, L .
JOURNAL OF CONTROLLED RELEASE, 2000, 64 (1-3) :263-268
[8]  
Conte U., 1998, PHARM TECH INT, V22, P174
[9]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[10]   Optimization and development of a core-in-cup tablet for modulated release of theophylline in simulated gastrointestinal fluids [J].
Danckwerts, MP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (07) :767-772